Darunavir/Cobicistat Is Associated with Negative Outcomes in HIV-Negative Patients with Severe COVID-19 Pneumonia.
AIDS Res Hum Retroviruses
; 37(4): 283-291, 2021 04.
Article
in En
| MEDLINE
| ID: mdl-33619997
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Anti-HIV Agents
/
Darunavir
/
Cobicistat
/
COVID-19 Drug Treatment
Type of study:
Observational_studies
/
Risk_factors_studies
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
AIDS Res Hum Retroviruses
Journal subject:
SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS)
Year:
2021
Document type:
Article
Affiliation country:
Italy
Country of publication:
United States